Aspen Pharmaceuticals: It will sell 100% equity interest in the Asia Pacific business other than China. The transaction valuation is 2.37 billion Australian dollars, and the corporate value/profit before interest, tax, depreciation and amortization ratio is about 11 times.

Aspen Pharmaceuticals: It will sell 100% equity interest in the Asia Pacific business other than China. The transaction valuation is 2.37 billion Australian dollars, and the corporate value/profit before interest, tax, depreciation and amortization ratio is about 11 times.